Iron pill safely fills iron stores in CKD patients with anaemia over long term
21 Jun 2021
byJairia Dela Cruz
In patients with chronic kidney disease (CKD) and iron-deficiency anaemia, the orally administered ferric maltol appears to yield meaningful and sustained increases in haemoglobin and iron indices, with a low rate of treatment discontinuation due to adverse events, according to the results of the phase III AEGIS-CKD trial and open-label extension.
